|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Restricted investment | ||||||||||||||||||||
| Restricted Investments | ||||||||||||||||||||
| Total restricted investment | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total accounts receivable, net | ||||||||||||||||||||
| Due from affiliates | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Ashford Trust | ||||||||||||||||||||
| Braemar | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Ashford Trust | ||||||||||||||||||||
| Braemar | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Ashford Trust | ||||||||||||||||||||
| Braemar | ||||||||||||||||||||
| Inventories ($137 and $386, respectively, attributable to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total inventories ($137 and $386, respectively, attributable to VIEs) | ||||||||||||||||||||
| Prepaid expenses and other assets ($352 and $530, respectively, attributable to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total prepaid expenses and other assets ($352 and $530, respectively, attributable to VIEs) | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Ashford Trust | ||||||||||||||||||||
| Property and equipment, net ($395 and $707, respectively, attributable to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total property and equipment, net ($395 and $707, respectively, attributable to VIEs) | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Total intangible assets, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total accounts payable and accrued expenses | ||||||||||||||||||||
| Dividends payable | ||||||||||||||||||||
| Series D Convertible Preferred Stock | ||||||||||||||||||||
| Total dividends payable | ||||||||||||||||||||
| Due to affiliates | ||||||||||||||||||||
| Total due to affiliates | ||||||||||||||||||||
| Due to Ashford Trust | ||||||||||||||||||||
| Deferred income ($207 and $210, respectively, attributable to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total deferred income ($207 and $210, respectively, attributable to VIEs) | ||||||||||||||||||||
| Deferred compensation plan | ||||||||||||||||||||
| Notes payable, net ($316 and $387, respectively, attributable to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total notes payable, net ($316 and $387, respectively, attributable to VIEs) | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Claims liabilities and other | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred income ($0 and $1,192, respectively, attributable to VIEs) | ||||||||||||||||||||
| Variable Interest Entity, Primary Beneficiary | ||||||||||||||||||||
| Total deferred income ($0 and $1,192, respectively, attributable to VIEs) | ||||||||||||||||||||
| Deferred tax liability, net | ||||||||||||||||||||
| Deferred compensation plan | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Total notes payable, net | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| MEZZANINE EQUITY | ||||||||||||||||||||
| Series D Convertible Preferred Stock, $0.001 par value, 19,120,000 shares issued and outstanding as of December 31, 2024 and December 31, 2023 | ||||||||||||||||||||
| Redeemable noncontrolling interests | ||||||||||||||||||||
| EQUITY (DEFICIT) | ||||||||||||||||||||
| Common stock, 100,000,000 shares authorized, $0.001 par value, 1,738,597 and 3,317,786 shares issued and 1,738,597 and 3,212,312 shares outstanding at December 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Treasury stock, at cost, 129,636 and 105,474 shares at March 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Treasury stock, at cost, 0 and 105,474 shares at December 31, 2024 and December 31, 2023, respectively | ||||||||||||||||||||
| Total equity (deficit) of the Company | ||||||||||||||||||||
| Noncontrolling interests in consolidated entities | ||||||||||||||||||||
| Total equity (deficit) | ||||||||||||||||||||
| Total liabilities, mezzanine equity and equity (deficit) | ||||||||||||||||||||
Loading...